Browse by Basel Contributors ID

Group by: Date | Item Type | Refereed | No Grouping

Bhadhuri, Arjun and Sutherland, C. Simone and Suter-Zimmermann, Katja and Schwenkglenks, Matthias and Rohrmann, Sabine and Hysaj, Ola and Tomonaga, Yuki and Pestoni, Giulia and Karavasiloglou, Nena. (8 July 2020) Vitamin D Testing. Health Technology Assessment (HTA). HTA Scoping Report.

Widén, Julia and Ivarsson, Magnus and Schalin, Lovisa and Vrouchou, Polina and Schwenkglenks, Matthias and Heimbürger, Olof and Ademi, Zanfina and Sutherland, C. Simone. (2020) Cost-Effectiveness Analysis of Patiromer in Combination with Renin-Angiotensin-Aldosterone System Inhibitors for Chronic Kidney Disease in Sweden. PharmacoEconomics, 38 (7). pp. 747-764.

Sutherland, C. S. and Tediosi, F.. (2019) Is the elimination of 'sleeping sickness' affordable? Who will pay the price? Assessing the financial burden for the elimination of human African trypanosomiasis Trypanosoma brucei gambiense in sub-Saharan Africa. BMJ Global Health, 4 (2). e001173.

Sutherland, C. Simone and Ademi, Zanfina and Michaud, Joëlle and Schur, Nadine and Lingg, Myriam and Bhadhuri, Arjun and Pache, Thierry D. and Bitzer, Johannes and Suchon, Pierre and Albert, Valerie and Hersberger, Kurt E. and Tanackovic, Goranka and Schwenkglenks, Matthias. (2019) Economic evaluation of a novel genetic screening test for risk of venous thromboembolism compared with standard of care in women considering combined hormonal contraception in Switzerland. BMJ open, 9 (11). e031325.

Pillai, Nadia and Lupatsch, Judith E. and Dusheiko, Mark and Schwenkglenks, Matthias and Maillard, Michel and Sutherland, C. Simone and Pittet, Valérie E. H. and Swiss IBD Cohort study group, . (2019) Evaluating the cost-effectiveness of early compared to late or no biologic treatment to manage Crohn's disease using real world data. Journal of Crohn's & colitis. jjz169.

Merritt, Maria W. and Sutherland, C. Simone and Tediosi, Fabrizio. (2018) Ethical considerations for global health decision-making : justice-enhanced cost-effectiveness analysis of new technologies for Trypanosoma brucei gambiense. Public health ethics, 11 (3). pp. 275-292.

Sutherland, C. Simone and Stone, Christopher M. and Steinmann, Peter and Tanner, Marcel and Tediosi, Fabrizio. (2017) Seeing beyond 2020 : an economic evaluation of contemporary and emerging strategies for elimination of Trypanosoma brucei gambiense. Lancet. Global health, 5 (1). e69-e79.

Ademi, Zanfina and Sutherland, C. Simone and Van Stiphout, Joris and Michaud, Jöelle and Tanackovic, Goranka and Schwenkglenks, Matthias. (2017) A systematic review of cost-effectiveness analysis of screening interventions for assessing the risk of venous thromboembolism in women considering combined oral contraceptives. Journal of thrombosis and thrombolysis, 44 (4). pp. 494-506.

Wwarn Gametocyte Study Group, . (2016) Gametocyte carriage in uncomplicated plasmodium falciparum malaria following treatment with artemisinin combination therapy : a systematic review and meta-analysis of individual patient data. BMC medicine, 14. p. 79.

Sutherland, Claudette Simone. An elimination investment case (EIC) for human African trypanosomiasis (HAT) Trypanosoma brucei (T.b.) gambiense ("sleeping sickness"). 2016, Doctoral Thesis, University of Basel, Faculty of Science.